Apyx Medical Corporation (APYX)
NASDAQ: APYX · Real-Time Price · USD
1.470
-0.110 (-6.96%)
May 14, 2025, 2:31 PM - Market open
Apyx Medical Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 47.29 | 48.1 | 52.35 | 44.51 | 48.52 | 27.71 | Upgrade
|
| Revenue Growth (YoY) | -6.27% | -8.11% | 17.61% | -8.26% | 75.08% | -1.86% | Upgrade
|
| Cost of Revenue | 18.21 | 18.74 | 18.59 | 15.38 | 14.92 | 10.21 | Upgrade
|
| Gross Profit | 29.08 | 29.36 | 33.76 | 29.13 | 33.6 | 17.5 | Upgrade
|
| Selling, General & Admin | 39.87 | 43.13 | 48.27 | 47.9 | 43.73 | 33.67 | Upgrade
|
| Research & Development | 4.49 | 5.08 | 5.44 | 4.54 | 4.32 | 3.92 | Upgrade
|
| Operating Expenses | 44.36 | 48.21 | 53.71 | 52.44 | 48.05 | 37.59 | Upgrade
|
| Operating Income | -15.28 | -18.85 | -19.95 | -23.31 | -14.45 | -20.08 | Upgrade
|
| Interest Expense | -5.89 | -5.91 | -2.48 | -0.02 | -0.01 | -0.05 | Upgrade
|
| Interest & Investment Income | 1.42 | 1.61 | 0.92 | 0.16 | 0.01 | 0.24 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.14 | -0.16 | 0.62 | 0.51 | -0.37 | 0.48 | Upgrade
|
| EBT Excluding Unusual Items | -19.89 | -23.31 | -20.89 | -22.66 | -14.82 | -19.41 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 2.69 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | -0.25 | - | - | Upgrade
|
| Other Unusual Items | - | - | -3.09 | - | - | - | Upgrade
|
| Pretax Income | -19.89 | -23.31 | -21.28 | -22.91 | -14.82 | -19.41 | Upgrade
|
| Income Tax Expense | 0.25 | 0.25 | -2.43 | 0.37 | 0.38 | -7.5 | Upgrade
|
| Earnings From Continuing Operations | -20.14 | -23.56 | -18.85 | -23.28 | -15.2 | -11.91 | Upgrade
|
| Net Income to Company | -20.14 | -23.56 | -18.85 | -23.28 | -15.2 | -11.91 | Upgrade
|
| Minority Interest in Earnings | 0.1 | 0.1 | 0.14 | 0.09 | 0.03 | 0.01 | Upgrade
|
| Net Income | -20.04 | -23.46 | -18.71 | -23.18 | -15.17 | -11.9 | Upgrade
|
| Net Income to Common | -20.04 | -23.46 | -18.71 | -23.18 | -15.17 | -11.9 | Upgrade
|
| Shares Outstanding (Basic) | 37 | 36 | 35 | 35 | 34 | 34 | Upgrade
|
| Shares Outstanding (Diluted) | 37 | 36 | 35 | 35 | 34 | 34 | Upgrade
|
| Shares Change (YoY) | 7.72% | 2.66% | 0.31% | 0.54% | 0.35% | 0.42% | Upgrade
|
| EPS (Basic) | -0.54 | -0.66 | -0.54 | -0.67 | -0.44 | -0.35 | Upgrade
|
| EPS (Diluted) | -0.54 | -0.66 | -0.54 | -0.67 | -0.44 | -0.35 | Upgrade
|
| Free Cash Flow | - | -18.77 | -5.78 | -21.29 | -11.17 | -16.65 | Upgrade
|
| Free Cash Flow Per Share | - | -0.53 | -0.17 | -0.62 | -0.33 | -0.49 | Upgrade
|
| Gross Margin | 61.49% | 61.04% | 64.49% | 65.45% | 69.26% | 63.17% | Upgrade
|
| Operating Margin | -32.31% | -39.18% | -38.11% | -52.38% | -29.78% | -72.47% | Upgrade
|
| Profit Margin | -42.37% | -48.78% | -35.75% | -52.09% | -31.27% | -42.93% | Upgrade
|
| Free Cash Flow Margin | - | -39.02% | -11.04% | -47.83% | -23.03% | -60.07% | Upgrade
|
| EBITDA | -14.69 | -18.25 | -19.26 | -22.42 | -13.55 | -19.2 | Upgrade
|
| EBITDA Margin | -31.06% | -37.93% | -36.79% | -50.38% | -27.92% | -69.27% | Upgrade
|
| D&A For EBITDA | 0.59 | 0.6 | 0.69 | 0.89 | 0.9 | 0.89 | Upgrade
|
| EBIT | -15.28 | -18.85 | -19.95 | -23.31 | -14.45 | -20.08 | Upgrade
|
| EBIT Margin | -32.31% | -39.18% | -38.11% | -52.38% | -29.78% | -72.47% | Upgrade
|
| Advertising Expenses | - | 1.3 | 1.8 | 2.3 | 1.3 | 0.8 | Upgrade
|
Updated May 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.